FOLH1 and prostate cancer: In fact, PSMA is a transmembrane glycoprotein significantly overexpressed on the epithelial cells of prostate cancers, particularly in those with aggressive biology, high Gleason score, and advanced stages (Bravaccini et al. 2018; Ahn et al. 2019).